See more : Rossari Biotech Limited (ROSSARI.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Cencosud S.A. (CENCOSUD.SN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cencosud S.A., a leading company in the Department Stores industry within the Consumer Cyclical sector.
- Ingersoll-Rand (India) Limited (INGERRAND.NS) Income Statement Analysis – Financial Results
- Aspire Global plc (ASPIRE.ST) Income Statement Analysis – Financial Results
- Lionheart Holdings (CUB) Income Statement Analysis – Financial Results
- Trident Acquisitions Corp. (TDACU) Income Statement Analysis – Financial Results
- Prima Industrie SpA (PRI.MI) Income Statement Analysis – Financial Results
Cencosud S.A. (CENCOSUD.SN)
About Cencosud S.A.
Cencosud S.A., together with its subsidiaries, operates as a retail conglomerate in Argentina, Brazil, Chile, Peru, and Colombia. It operates supermarkets, home improvement stores, department stores, shopping centers, and insurance brokerage and family entertainment centers; and provides financial services. The company was founded in 1963 and is based in Las Condes, Chile.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 14,230.64B | 14,202.10B | 11,760.07B | 9,836.12B | 9,548.21B | 9,646.00B | 10,456.99B | 10,333.00B | 10,991.34B | 10,711.03B | 10,134.16B | 9,149.08B | 7,569.20B | 6,194.71B | 5,512.42B |
Cost of Revenue | 10,069.30B | 10,129.99B | 8,327.46B | 7,191.85B | 6,877.27B | 6,885.36B | 7,458.83B | 7,356.47B | 7,813.23B | 7,814.77B | 7,311.73B | 6,547.83B | 5,429.86B | 4,448.94B | 4,039.25B |
Gross Profit | 4,161.34B | 4,072.10B | 3,432.62B | 2,644.27B | 2,670.94B | 2,760.64B | 2,998.16B | 2,976.53B | 3,178.11B | 2,896.26B | 2,822.43B | 2,601.25B | 2,139.34B | 1,745.77B | 1,473.16B |
Gross Profit Ratio | 29.24% | 28.67% | 29.19% | 26.88% | 27.97% | 28.62% | 28.67% | 28.81% | 28.91% | 27.04% | 27.85% | 28.43% | 28.26% | 28.18% | 26.72% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 3,226.79B | 2,716.36B | 2,101.60B | 1,990.45B | 2,059.10B | 2,167.59B | 2,372.58B | 2,325.90B | 2,473.34B | 2,495.44B | 2,194.03B | 1,925.41B | 1,519.38B | 1,213.74B | 1,058.24B |
Selling & Marketing | 0.00 | 113.55B | 99.05B | 67.86B | 32.06B | 33.04B | 29.93B | 26.82B | 27.87B | 26.65B | 23.93B | 20.23B | 15.02B | 11.36B | 9.28B |
SG&A | 3,226.79B | 2,829.91B | 2,200.65B | 2,058.31B | 2,091.16B | 2,200.63B | 2,402.51B | 2,352.72B | 2,501.21B | 2,495.44B | 2,217.96B | 1,945.65B | 1,534.40B | 1,225.10B | 1,067.52B |
Other Expenses | -64.47B | 155.92B | 144.02B | 108.47B | 147.43B | -1.08B | 17.56B | 360.72B | 147.44B | 149.06B | 10.03B | 10.18B | -30.41B | -4.60B | 50.25B |
Operating Expenses | 3,162.32B | 2,985.83B | 2,344.67B | 2,166.78B | 2,238.59B | 2,365.71B | 2,589.79B | 2,523.38B | 2,675.49B | 2,495.44B | 2,370.10B | 2,121.82B | 1,589.67B | 1,303.03B | 1,175.25B |
Cost & Expenses | 13,231.62B | 13,115.82B | 10,672.12B | 9,358.63B | 9,115.86B | 9,251.07B | 10,048.61B | 9,879.85B | 10,488.71B | 10,310.21B | 9,681.83B | 8,669.65B | 7,019.52B | 5,751.97B | 5,214.51B |
Interest Income | 115.89B | 62.10B | 17.23B | 33.63B | 19.58B | 13.07B | 14.90B | 14.54B | 14.94B | 6.43B | 5.97B | 8.11B | 39.19B | 16.86B | 3.70B |
Interest Expense | 448.58B | 97.23B | 46.38B | 272.40B | 272.64B | 236.94B | 271.88B | 267.08B | 244.10B | 215.46B | 206.61B | 211.02B | 136.73B | 79.61B | 82.31B |
Depreciation & Amortization | -305.98B | 363.64B | 278.84B | 373.60B | 317.74B | 214.58B | 242.05B | 227.71B | -115.51B | -88.71B | -69.07B | 93.97B | -13.92B | 19.77B | 89.32B |
EBITDA | 693.04B | 1,360.16B | 1,225.06B | 844.64B | 904.75B | 692.50B | 1,132.38B | 1,062.66B | 525.38B | 606.23B | 542.08B | 573.39B | 537.77B | 462.51B | 479.59B |
EBITDA Ratio | 4.87% | 5.06% | 6.92% | 4.93% | 5.51% | 5.38% | 8.56% | 8.21% | 4.78% | 4.63% | 5.23% | 6.27% | 7.45% | 7.47% | 7.02% |
Operating Income | 999.03B | 1,122.92B | 1,035.30B | 593.72B | 713.61B | 608.91B | 825.41B | 813.87B | 650.07B | 549.88B | 586.98B | 479.42B | 578.15B | 442.74B | 297.91B |
Operating Income Ratio | 7.02% | 7.91% | 8.80% | 6.04% | 7.47% | 6.31% | 7.89% | 7.88% | 5.91% | 5.13% | 5.79% | 5.24% | 7.64% | 7.15% | 5.40% |
Total Other Income/Expenses | -485.64B | -480.99B | -279.47B | -391.16B | -384.14B | -330.56B | -186.99B | -234.10B | -368.78B | -231.33B | -221.98B | -200.35B | -173.70B | -59.43B | -861.84M |
Income Before Tax | 513.39B | 641.93B | 755.83B | 202.56B | 329.46B | 278.35B | 638.42B | 579.77B | 281.28B | 280.10B | 335.48B | 362.00B | 417.62B | 380.58B | 302.42B |
Income Before Tax Ratio | 3.61% | 4.52% | 6.43% | 2.06% | 3.45% | 2.89% | 6.11% | 5.61% | 2.56% | 2.62% | 3.31% | 3.96% | 5.52% | 6.14% | 5.49% |
Income Tax Expense | 221.17B | 237.19B | 260.69B | 137.58B | 174.85B | 87.75B | 198.28B | 191.97B | 58.54B | 100.49B | 94.07B | 109.19B | 119.20B | 76.17B | 54.07B |
Net Income | 220.28B | 338.93B | 471.91B | 64.98B | 154.62B | 191.29B | 439.99B | 387.80B | 231.99B | 191.89B | 249.93B | 249.96B | 298.43B | 306.48B | 247.55B |
Net Income Ratio | 1.55% | 2.39% | 4.01% | 0.66% | 1.62% | 1.98% | 4.21% | 3.75% | 2.11% | 1.79% | 2.47% | 2.73% | 3.94% | 4.95% | 4.49% |
EPS | 77.30 | 119.10 | 165.60 | 22.76 | 54.16 | 66.81 | 153.70 | 135.47 | 82.01 | 67.80 | 90.40 | 106.50 | 121.20 | 129.18 | 108.52 |
EPS Diluted | 77.00 | 118.86 | 165.35 | 22.74 | 54.16 | 66.81 | 153.70 | 135.47 | 82.01 | 67.80 | 89.80 | 106.50 | 120.00 | 127.90 | 108.52 |
Weighted Avg Shares Out | 2.85B | 2.85B | 2.85B | 2.86B | 2.86B | 2.86B | 2.86B | 2.86B | 2.83B | 2.83B | 2.76B | 2.33B | 2.26B | 2.29B | 2.25B |
Weighted Avg Shares Out (Dil) | 2.86B | 2.85B | 2.85B | 2.86B | 2.86B | 2.86B | 2.86B | 2.86B | 2.83B | 2.83B | 2.78B | 2.35B | 2.29B | 2.32B | 2.25B |
Source: https://incomestatements.info
Category: Stock Reports